Log in to save to my catalogue

Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant...

Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ccff0791e1db452b9fa98973d83e2bed

Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis

About this item

Full title

Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis

Publisher

United States: Public Library of Science

Journal title

PLoS neglected tropical diseases, 2025-03, Vol.19 (3), p.e0012864

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the main risk factor for severe haemolysis following treatment with 8-aminoquinolines (8AQ). The World Health Organization recommends G6PD testing prior to 8AQ-based hypnozoitocidal treatment.
We undertook an individual level meta-analysis of the performance of commercially available quantit...

Alternative Titles

Full title

Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ccff0791e1db452b9fa98973d83e2bed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ccff0791e1db452b9fa98973d83e2bed

Other Identifiers

ISSN

1935-2735,1935-2727

E-ISSN

1935-2735

DOI

10.1371/journal.pntd.0012864

How to access this item